These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32737645)

  • 1. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.
    Avilés-Jurado FX; Muñoz C; Meler C; Flores JC; Gumà J; Benaiges E; Mora J; Camacho M; León X; Vilaseca I; Terra X
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1585-1594. PubMed ID: 32737645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
    Chamorro Petronacci CM; García García A; Padín Iruegas E; Rivas Mundiña B; Lorenzo Pouso AI; Pérez Sayáns M
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33066067
    [No Abstract]   [Full Text] [Related]  

  • 4. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
    EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
    Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
    Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
    Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
    Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
    Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
    Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miRNA in head and neck squamous cell carcinoma.
    Masood Y; Kqueen CY; Rajadurai P
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.
    Ahmad P; Sana J; Slavik M; Gurin D; Radova L; Gablo NA; Kazda T; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Slaby O
    Cancer Genomics Proteomics; 2019; 16(2):139-146. PubMed ID: 30850365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
    Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
    Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
    Conrad O; Burgy M; Foppolo S; Jehl A; Thiéry A; Guihard S; Vauchelles R; Jung AC; Mourtada J; Macabre C; Ledrappier S; Chenard MP; Onea MA; Danic A; Dourlhes T; Thibault C; Schultz P; Dontenwill M; Martin S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.